Join
Live feed
·
INSIDERFilingvia Quantisnow
Tenax Therapeutics Inc. logo

CEO Giordano Christopher Thomas exercised 8,719 shares at a strike of $5.88, increasing direct ownership by 335% to 11,324 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TENX· Tenax Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TENX (Tenax Therapeutics Inc.) and more on Quantisnow.